Rahpouyan Fanavar Sadegh

Rahpouyan Fanavar Sadegh (RFS Biotech) is an Iranian biotechnology company founded in 2019 and headquartered in the Pardis Technology Park in Tehran. The company focuses on the research, development, and manufacture of recombinant proteins and polysaccharide vaccines, including conjugate and non-conjugate vaccines targeting Haemophilus influenzae type b (Hib), Streptococcus pneumoniae (pneumococcus), and Neisseria meningitidis (meningitis). RFS Biotech operates a state-of-the-art manufacturing facility designed in compliance with cGMP, EU-GMP, and WHO regulatory standards to support domestic vaccine supply and future export markets. Additionally, the company serves as a distributor of pharmaceutical products and vaccines in Iran, and collaborates closely with academic institutions like Shahid Beheshti University and the University of Tehran on bioprocess optimization and novel adjuvant technologies.